Bank of Montreal’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-9,298
Closed -$80K 5016
2018
Q2
$80K Sell
9,298
-879
-9% -$7.91K ﹤0.01% 3235
2018
Q1
$103K Buy
+10,177
New +$85.5K ﹤0.01% 2956
2015
Q4
Sell
-7,810
Closed -$92K 4538
2015
Q3
$92K Buy
+7,810
New +$86.3K ﹤0.01% 2664

Bank of Montreal's JNP Position: Q3 2018 in Review

Bank of Montreal sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 9,298 shares — an estimated $80K sold.

Bank of Montreal first reported a position in JNP in Q3 2015 and held it in 3 quarters. The position peaked at $103K in Q1 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

  • Bank of Montreal reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Bank of Montreal sold 9,298 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $80K.
  • Bank of Montreal first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2015 and held it in 3 quarters.
  • Bank of Montreal's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $103K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Bank of Montreal's 13F filing for Q3 2018, filed 12 Oct 2018.